Development and Implementation of the Use of Optically Stimulated Luminescent Detectors in the Radiological Physics Center Anthropomorphic Quality Assurance Phantoms
J Bergene1,2*, S Kry1, A Molineu1, D Bellezza3, L Court1, P Alvarez1, V Johnson1, D Followill1, (1) UT MD Anderson Cancer Center, Houston, Texas (2) University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas (3) St. Luke's Episcopal Hospital, Houston, TexasSU-E-T-86 Sunday 3:00:00 PM - 6:00:00 PM Room: Exhibit Hall
Purpose: To study the angular dependence of optically stimulated luminescence dosimeters (OSLD) in the Radiological Physics Center anthropomorphic quality assurance pelvic phantom to provide accurate dosimetric measurements as a replacement for TLD.
Methods: A spherical phantom was constructed to investigate the angular response of the OSLD as oriented in the RPC pelvic phantom. Three OSLD per irradiation angle, placed at the center of the spherical phantom, were irradiated with 100 cGy from six different angles. The angular response at each angle was determined relative to the OSLD response when the beam was incident normally on the OSLD surface. A pelvic phantom dosimetry insert was modified to include both TLD and OSLD. Three treatment plans were developed in Pinnacle v9.0 and one in Accuray's Multiplan, each with increasing angular beam delivery (4 field, IMRT, SmartArc, CyberKnife) for the pelvic phantom using a common dose prescription and constraints. Each plan was delivered to the phantom three times, containing two TLD and two OSLD, oriented in the transverse plane, at the center of the PTV. The dose delivered to the TLD and OSLD was calculated for each treatment and then compared.
Results: The angular dependence correction factor for the spherical phantom was found to be uniformly 1.041 ± 0.003 from single beam edge-on irradiations. The angular dependence correction in the pelvic phantom from multiple beam orientation irradiations was 1.024 ± 0.002, such that the OSLD dose agreed with the TLD dose. Applying the OSLD pelvic phantom correction factor, the RPC measured dose to planning system calculated dose ratio was 0.995 ± 0.009. The established RPC phantom TLD dose to calculated dose ratio was 0.995 ± 0.010.
Conclusions: An anthropomorphic phantom OSLD angular dependence correction factor was established such that the final OSLD dose measurements agreed with RPC's TLD dose measurements to within 1%.